Register for IPO Updates
US IPO Stats
IPO Industry Breakdown
Largest Global IPOs
Largest US IPOs
IPO News Archive
New Ways to Invest in IPOs - IPO ETFs
Week ahead: 11 IPOs set to price during the week of September 28
Analyst IPO Market Commentary
The last week of September has 11 IPOs on
– more IPOs than all of August 2015.
Out of 134 offerings so far in 2015, 61 have been health care companies. Next week, 7 out of the 11 IPOs on the calendar are health care. A large foodservice distributor and three microcap Chinese manufacturers round out the group.
The third largest US food service distributor with a 6% share, after leaders Sysco and US Foods,
Performance Food Group
) was acquired in 2008 by Blackstone for $1.3 billion and is now growing faster than its larger rivals. Performance's momentum is driven by its Foodservice segment (59% of sales), serving independent restaurants and pizzerias, and its Vistar vending segment (16%), serving coffee and snack foods to offices, colleges and big box retailers. Performance plans to grow through further customer penetration in each segment, focusing on higher margin customers, growing proprietary brands and acquisitions. The company expects to raise $341 million.
Health care and biotech
LBO’d surgical center operator
) has delivered strong same-facility growth since 2012 in the highly fragmented ambulatory surgical center (ASC) market. The company looks to raise $350 million, making it the largest deal next week. Backed by over $450 million in institutional and venture funding,
) markets a wearable electric field device for treating glioblastoma brain cancer. The device, Optune, was approved by the FDA in 2011 and has been used to treat over 1,600 patients. The company hopes to raise $344 million to help fund its heavy losses.
) received orphan drug designation from the FDA in May 2015 for its sustained exposure therapies for bleeding around the brain. Backed by Sofinnova, Venrock and Janus, the company expects to raise $85 million.
) is developing microRNA replacement therapies for liver cancer and hopes to raise $65 million. RA Capital-backed
) has raised $70 million in private funding for development of therapies for rare endocrine disorders. Next week it expects to raise another $76 million in its offering.
), which is developing adjunctive treatment for major depressive disorder, is looking to raise $27 million.
) is developing and commercializing the SynCardia temporary Total Artificial Heart, or TAH-t, the only total artificial heart commercially available in the US, European Union and Canada. It hopes to raise $28 million. The company initiated a recall of a system used with the TAH-t after a patient’s primary unit alarmed and stopped pumping, causing him to lose consciousness. In mid-September, the FDA followed up with a Class I recall on the system.
), which originally set terms on July 28, hopes to raise $10 million. The company postponed its IPO in early August, then revised its terms downward from a $96 million proposed market cap to a $68 million proposed market cap. It sells display products, including standard projectors, interactive projectors and interactive LED flat panels, as well as audio systems, mounting devices and mobile stands.
Sole Elite Group
) is a profitable designer and producer of foam and rubber shoe soles used to manufacture sports shoes. It expects to raise $33 million in its IPO.
) is a manufacturer of disposable plastic products for US quick service restaurants (QSRs) that supplies four of the five largest fast food chains: Wendy’s, McDonald’s, Subway and Burger King. It plans to raise $30 million.
Renaissance Capital's IPO Calendar - Week of
$23.00 - $26.00
BofA Merrill Lynch
Owns or operates 99 surgical facilities across 28 states.
St Helier, Jersey
$26.00 - $29.00
Markets a wearable electric field device for treating glioblastoma brain cancer.
Performance Food Group
$22.00 - $25.00
Third-largest US foodservice distributor LBO'd by Blackstone.
Berkeley Heights, NJ
$14.00 - $16.00
Developing a sustained-release therapy for ruptured brain aneurysms.
$17.93 - $17.93
BofA Merrill Lynch
Late-stage biotech developing therapies for rare endocrine disorders.
$13.00 - $15.00
Developing microRNA replacement therapies for liver cancer.
Sole Elite Group
$10.00 - $12.00
Chinese athletic shoe sole manufacturer.
$5.00 - $7.00
Chinese producer of disposable plastic cutlery and other food service products.
$10.00 - $12.00
Developer and manufacturer of temporary implantable artificial hearts.
$6.00 - $7.00
Maxim Group LLC
Developing a novel adjunct therapy for major depressive disorder.
$8.00 - $10.00
Aegis Capital Corp.
Manufactures interactive projectors and other classroom materials.
Source: IPO ETF manager Renaissance Capital
Find out why institutional investors rely on Renaissance Capital's
for these IPOs.
Follow us on Twitter (
) for IPO news as it happens and
register for our updates
on the IPO market.
IPO pipeline update: The billion-dollar IPO club
In the pipeline, highly-anticipated tech IPO
Pure Storage (
), which hopes to raise $425 million, and Caribbean mobile service provider
), which expects to raise $1.8 billion, filed terms this week. Both are expected to price during the week of October 5. There are numerous IPOs in the pipeline that we estimate could raise over $1 billion, including notable names
First Data (
), which could be the largest IPO of the year,
Neiman Marcus (
). All have been on file since the beginning of August or earlier, yet none have announced an IPO date.
IPO Market Snapshot
Strong IPO volume in the fourth quarter will in part hinge on improved returns for recent IPOs. The Renaissance IPO Index has traded down 10.5% year-to-date, compared to -6.2% for the S&P 500. Renaissance Capital's
(NYSE: IPO) tracks the index, and
top ETF holdings
include Alibaba (
), Hilton Worldwide (
) and Twitter (
). In the past month, Alibaba and Twitter fell below their IPO prices for the first time. The Renaissance International IPO Index has traded down 4.6% year-to-date, compared to -9.1% for the ACWX. Renaissance Capital’s International
(NYSE: IPOS) tracks the index, and
top ETF Holdings
include Recruit Holdings and Cheil Industries.
Keywords / Tickers:
Recently Priced IPOs
ETF Express Award:
ETFExpress awards are based on a 'peer review system' whereby readers - including institutional and high net worth investors as well as managers and other industry professionals at fund administrators, brokers, custodians and advisers - are invited to elect a 'best in class' in a series of categories via an online survey. In each category, the firms with the most votes at the end of the voting period are subject to a final review by ETFExpress's Senior Editorial team.
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the original cost. Investors should consider the investment objectives, risks, charges and expenses carefully before investing.
As stated in the Prospectus, the total annual operating expenses for the Fund was 3.48%. The Adviser has contractually agreed to keep net expenses from exceeding 2.50% of the Fund's average daily net assets for at least a year from the date of the Prospectus and for an indefinite period thereafter subject to annual re-approval of the agreement by the Board of Trustees.
An investor cannot invest directly in an index. Index returns do not represent Fund returns. The Index does not charge management fees or brokerage expenses, nor does the Index lend securities, and no revenues from securities lending were added to the performance shown.
Definitions: Net Asset Value (NAV) of the fund is calculated by dividing the total value of all the securities in its portfolio, less any liabilities, by the number of fund shares outstanding. Market Price is current value at which an asset or service can be bought or sold. Premium/Discount is provided to show the comparison of the daily net asset value (NAV) and the midpoint of the closing bid/ask for each of the funds.
Renaissance IPO Index® (IPOUSA)
is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios.
Renaissance International IPO Index® (IPOXUS)
is a stock market index based upon a portfolio of newly public companies listed on non-U.S. exchanges.
The S&P 500® Index (SPX) is a stock market index which includes 500 U.S. listed companies and seeks to capture approximately 80% coverage of available U.S. market capitalization.
Risk Disclosure: Investments in the
Renaissance IPO ETF, symbol "IPO"
Renaissance International IPO ETF, symbol "IPOS"
(the "ETFs"), and the
Global IPO Fund, symbol "IPOSX"
(the "Mutual Fund") are subject to investment risk, including possible loss of the principal amounts invested. The ETFs and the Mutual Fund (the "Funds") invest in companies that have recently completed initial public offerings. These stocks are unseasoned equities lacking trading history, a track record of reporting to investors and widely available research coverage which many result in extreme price volatility. Due to a greater number of IPOs in certain segments, the Funds may also be subject to information technology and financial sector risk, small and mid-capitalization company risk, and, for the Renaissance International IPO ETF, emerging markets risk. The Funds may hold securities in the form of Depository Receipts, REITs, and Partnership Units which have greater risks than common shares. The strategies have high portfolio turnover and securities lending risks. The returns of the ETFs may not match the return of the respective indices. The ETFs are classified as non-diversified investment companies subject to concentration risk.
Prospectus: Investors should consider the investment objectives, risks, charges and expenses carefully before investing. For a prospectus and/or summary prospectus with this and other information, please visit
. Read the prospectus carefully before investing. Renaissance Capital Investments, Inc., distributor for the Mutual Fund. Foreside Fund Services, LLC, distributor for the ETFs, 1-866-486-6645.
Definitions: The Renaissance IPO Index® is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios. The S&P 500® Index is a stock market index based on the market capitalizations of 500 large companies whose common stock is publicly traded on the NYSE or Nasdaq.
The information contained herein is proprietary and copyrighted. The media is welcome to use our information and ideas, provided that the following sourcing is included: Renaissance Capital - manager of IPO-focused ETFs.
The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO), the Renaissance International IPO ETF (symbol: IPOS), or the Global IPO Fund (symbol: IPOSX), may have investments in securities of companies mentioned.
Register for Updates
Renaissance Capital LLC is an SEC-registered investment adviser.
Renaissance Capital Investments, Inc. is a
-registered broker-dealer, and member of
© 2016 Renaissance Capital LLC. All rights reserved.